Valuation : Paion AG

Market Cap 144K 168K 136K 124K 232K 16.02M 234K 1.62M 623K 8.13M 629K 615K 25.81M P/E 2021
-3.89x
P/E 2022 -53x
Enterprise Value 9.87M 11.47M 9.31M 8.48M 15.85M 1.1B 16M 111M 42.67M 556M 43.08M 42.14M 1.77B EV / Sales 2021
14.1x
EV / Sales 2022 1.22x
Free-Float
100%
Yield 2021 *
-
Yield 2022 -
1 week+4.35%
Current month+4.35%
1 month+3.23%
3 months-10.28%
6 months-27.27%
Current year+263.64%
1 week 0.05
Extreme 0.046
0.05
1 month 0.04
Extreme 0.044
0.05
Current year 0.01
Extreme 0.012
0.23
1 year 0.01
Extreme 0.009
0.23
3 years 0
Extreme 0.0001
5
5 years 0
Extreme 0.0001
18.94
10 years 0
Extreme 0.0001
36.78
Manager TitleAgeSince
Chief Executive Officer 62 2023-08-31
Director of Finance/CFO - 2022-05-31
Director TitleAgeSince
Director/Board Member 65 2012-09-30
Director/Board Member 75 2017-05-31
Director/Board Member - 2019-05-21
Date Insider Type Main position Quantity % Market Cap. Importance
12/27/22 Buy

Director

1,121 0.0016%
1/12/21 Buy

Chief Executive Officer

8,500 0.0127%
6/8/20 Buy

Chief Executive Officer

13,158 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+4.35%+433.33%-99.07% 398K
-0.56%-8.08%-3.88%+10.58% 46.38B
-2.08%-3.57%+402.72%+533.09% 44.51B
+0.12%-5.27%+39.94%+20.50% 42.3B
-2.62%-5.76%+8.88%+77.44% 39.91B
-1.26%-3.37%+11.87%+40.55% 32.79B
+0.16%-3.65% - - 17.13B
-0.54%-1.72%+22.34%+115.10% 16.36B
-0.03%-3.46%+12.68%+30.90% 14.31B
-1.92%-6.94%+78.12%+36.68% 13.29B
Average -0.87%-3.43%+111.78%+85.08% 26.7B
Weighted average by Cap. -1.09%-4.54%+87.11%+129.36%

Financials

2021 2022
Net sales 7.13M 8.29M 6.73M 6.13M 11.45M 792M 11.56M 80.1M 30.83M 402M 31.13M 30.45M 1.28B 33.25M 38.66M 31.37M 28.58M 53.42M 3.7B 53.91M 374M 144M 1.87B 145M 142M 5.95B
Net income -21.79M -25.33M -20.56M -18.73M -35.01M -2.42B -35.32M -245M -94.22M -1.23B -95.13M -93.05M -3.9B -579K -673K -546K -498K -930K -64.37M -939K -6.51M -2.5M -32.65M -2.53M -2.47M -104M
Net Debt 13.77M 16.01M 12.99M 11.84M 22.12M 1.53B 22.33M 155M 59.55M 776M 60.12M 58.81M 2.47B 9.72M 11.31M 9.17M 8.36M 15.62M 1.08B 15.76M 109M 42.05M 548M 42.46M 41.53M 1.74B
Logo Paion AG
Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In addition to that, remimazolam, which is in Phase III clinical development, can be reversed with flumazenil to terminate sedation and anesthesia, if necessary. The product can be used for general anesthesia in Europe and procedural sedation in the United States. The Company operates sites in Aachen, Germany, Cambridge, the United Kingdom, and New Jersey, the United States.
Employees
64
Date Price Change Volume
26-09-10 €0.0480 0.00% 0
26-09-09 €0.0480 +4.35% 0
26-09-08 €0.0460 0.00% 0
26-09-07 €0.0460 0.00% 0
26-09-04 €0.0460 0.00% 0
  1. Stock Market
  2. Stocks
  3. PA8K Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!